BELLUS Health Inc. announced that it has closed an equity offering, issuing a total of 36,842,105 common shares for gross proceeds of $35 million. The Offering was led by OrbiMed and also included New Leaf Venture Partners, First Manhattan Co., Samsara BioCapital, Fonds de solidarité FTQ, AppleTree Partners and Amzak Health. In connection with the financing, Mr. Chau Q. Khuong, Partner at OrbiMed, has joined the company's Board of Directors.